annual EBITDA:
$100.16M+$167.99M(+247.67%)Summary
- As of today (June 19, 2025), ACAD annual EBITDA is $100.16 million, with the most recent change of +$167.99 million (+247.67%) on December 31, 2024.
- During the last 3 years, ACAD annual EBITDA has risen by +$267.26 million (+159.94%).
- ACAD annual EBITDA is now at all-time high.
Performance
ACAD EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$22.24M+$10.04M(+82.27%)Summary
- As of today (June 19, 2025), ACAD quarterly EBITDA is $22.24 million, with the most recent change of +$10.04 million (+82.27%) on March 31, 2025.
- Over the past year, ACAD quarterly EBITDA has increased by +$1.50 million (+7.25%).
- ACAD quarterly EBITDA is now -39.20% below its all-time high of $36.58 million, reached on December 31, 2023.
Performance
ACAD quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$101.67M+$1.50M(+1.50%)Summary
- As of today (June 19, 2025), ACAD TTM EBITDA is $101.67 million, with the most recent change of +$1.50 million (+1.50%) on March 31, 2025.
- Over the past year, ACAD TTM EBITDA has increased by +$95.60 million (+1575.15%).
- ACAD TTM EBITDA is now -18.37% below its all-time high of $124.54 million, reached on September 30, 2024.
Performance
ACAD TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ACAD EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +247.7% | +7.3% | +1575.2% |
| 3 y3 years | +159.9% | +119.8% | +147.6% |
| 5 y5 years | +141.1% | +125.0% | +141.4% |
ACAD EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +145.2% | -39.2% | +119.8% | -18.4% | +145.9% |
| 5 y | 5-year | at high | +135.3% | -39.2% | +119.8% | -18.4% | +135.8% |
| alltime | all time | at high | +134.6% | -39.2% | +119.8% | -18.4% | +132.9% |
ACAD EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $22.24M(+82.3%) | $101.67M(+1.5%) |
| Dec 2024 | $100.16M(-247.7%) | $12.20M(-64.3%) | $100.16M(-19.6%) |
| Sep 2024 | - | $34.21M(+3.7%) | $124.54M(+263.4%) |
| Jun 2024 | - | $33.01M(+59.2%) | $34.27M(+464.7%) |
| Mar 2024 | - | $20.74M(-43.3%) | $6.07M(-108.9%) |
| Dec 2023 | -$67.83M(-69.4%) | $36.58M(-165.3%) | -$67.83M(-54.8%) |
| Sep 2023 | - | -$56.05M(-1267.0%) | -$149.98M(+20.7%) |
| Jun 2023 | - | $4.80M(-109.0%) | -$124.29M(-23.4%) |
| Mar 2023 | - | -$53.16M(+16.6%) | -$162.23M(-26.8%) |
| Dec 2022 | -$221.57M(+32.6%) | -$45.57M(+50.1%) | -$221.57M(+0.7%) |
| Sep 2022 | - | -$30.36M(-8.4%) | -$220.12M(+7.9%) |
| Jun 2022 | - | -$33.14M(-70.5%) | -$204.07M(-4.5%) |
| Mar 2022 | - | -$112.50M(+155.0%) | -$213.72M(+27.9%) |
| Dec 2021 | -$167.09M(-41.1%) | -$44.12M(+208.2%) | -$167.09M(-11.7%) |
| Sep 2021 | - | -$14.32M(-66.5%) | -$189.30M(-27.2%) |
| Jun 2021 | - | -$42.78M(-35.1%) | -$260.17M(-0.2%) |
| Mar 2021 | - | -$65.88M(-0.7%) | -$260.68M(-8.1%) |
| Dec 2020 | -$283.65M(+16.4%) | -$66.32M(-22.1%) | -$283.65M(+3.9%) |
| Sep 2020 | - | -$85.19M(+96.8%) | -$273.09M(+17.4%) |
| Jun 2020 | - | -$43.29M(-51.3%) | -$232.67M(-5.3%) |
| Mar 2020 | - | -$88.85M(+59.3%) | -$245.78M(+0.8%) |
| Dec 2019 | -$243.78M(-0.3%) | -$55.76M(+24.6%) | -$243.78M(-4.2%) |
| Sep 2019 | - | -$44.77M(-20.6%) | -$254.51M(-5.8%) |
| Jun 2019 | - | -$56.40M(-35.1%) | -$270.26M(-2.5%) |
| Mar 2019 | - | -$86.85M(+30.6%) | -$277.23M(+13.4%) |
| Dec 2018 | -$244.44M(-15.6%) | -$66.49M(+9.9%) | -$244.44M(-1.1%) |
| Sep 2018 | - | -$60.52M(-4.5%) | -$247.25M(-1.8%) |
| Jun 2018 | - | -$63.37M(+17.2%) | -$251.68M(-1.6%) |
| Mar 2018 | - | -$54.06M(-22.0%) | -$255.67M(-11.7%) |
| Dec 2017 | -$289.70M(+6.9%) | -$69.31M(+6.7%) | -$289.70M(-2.8%) |
| Sep 2017 | - | -$64.95M(-3.6%) | -$297.99M(-2.2%) |
| Jun 2017 | - | -$67.36M(-23.5%) | -$304.83M(-1.3%) |
| Mar 2017 | - | -$88.08M(+13.5%) | -$308.94M(+14.0%) |
| Dec 2016 | -$270.99M(+65.3%) | -$77.60M(+8.1%) | -$270.99M(+13.5%) |
| Sep 2016 | - | -$71.79M(+0.4%) | -$238.82M(+16.0%) |
| Jun 2016 | - | -$71.47M(+42.6%) | -$205.91M(+18.6%) |
| Mar 2016 | - | -$50.12M(+10.3%) | -$173.66M(+5.9%) |
| Dec 2015 | -$163.97M(+76.3%) | -$45.44M(+16.9%) | -$163.97M(+11.5%) |
| Sep 2015 | - | -$38.88M(-0.9%) | -$147.02M(+10.5%) |
| Jun 2015 | - | -$39.22M(-3.0%) | -$133.07M(+15.2%) |
| Mar 2015 | - | -$40.43M(+41.9%) | -$115.54M(+24.2%) |
| Dec 2014 | -$93.02M(+143.4%) | -$28.49M(+14.3%) | -$93.02M(+21.4%) |
| Sep 2014 | - | -$24.93M(+15.0%) | -$76.66M(+22.6%) |
| Jun 2014 | - | -$21.68M(+21.0%) | -$62.52M(+25.1%) |
| Mar 2014 | - | -$17.91M(+47.8%) | -$49.98M(+30.8%) |
| Dec 2013 | -$38.22M | -$12.13M(+12.3%) | -$38.22M(+16.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2013 | - | -$10.79M(+18.0%) | -$32.89M(+34.2%) |
| Jun 2013 | - | -$9.14M(+48.7%) | -$24.50M(+17.9%) |
| Mar 2013 | - | -$6.15M(-9.5%) | -$20.79M(-0.4%) |
| Dec 2012 | -$20.78M(-7.9%) | -$6.80M(+182.4%) | -$20.86M(+7.8%) |
| Sep 2012 | - | -$2.41M(-55.7%) | -$19.35M(-12.1%) |
| Jun 2012 | - | -$5.43M(-12.9%) | -$22.01M(-4.8%) |
| Mar 2012 | - | -$6.23M(+17.9%) | -$23.13M(+2.5%) |
| Dec 2011 | -$22.57M(-243.7%) | -$5.28M(+4.4%) | -$22.57M(-287.4%) |
| Sep 2011 | - | -$5.06M(-22.7%) | $12.04M(-7.1%) |
| Jun 2011 | - | -$6.55M(+15.4%) | $12.96M(-15.6%) |
| Mar 2011 | - | -$5.67M(-119.3%) | $15.35M(-2.2%) |
| Dec 2010 | $15.70M(-135.4%) | $29.32M(-808.1%) | $15.70M(-171.8%) |
| Sep 2010 | - | -$4.14M(-0.4%) | -$21.88M(-16.8%) |
| Jun 2010 | - | -$4.16M(-21.9%) | -$26.30M(-24.3%) |
| Mar 2010 | - | -$5.32M(-35.6%) | -$34.74M(-21.7%) |
| Dec 2009 | -$44.36M(-32.7%) | -$8.26M(-3.4%) | -$44.36M(-11.8%) |
| Sep 2009 | - | -$8.55M(-32.1%) | -$50.31M(-11.8%) |
| Jun 2009 | - | -$12.60M(-15.7%) | -$57.06M(-9.4%) |
| Mar 2009 | - | -$14.94M(+5.2%) | -$62.99M(-5.0%) |
| Dec 2008 | -$65.94M(+6.5%) | -$14.21M(-7.2%) | -$66.33M(-5.4%) |
| Sep 2008 | - | -$15.31M(-17.4%) | -$70.08M(-3.6%) |
| Jun 2008 | - | -$18.53M(+1.4%) | -$72.66M(+8.9%) |
| Mar 2008 | - | -$18.28M(+1.8%) | -$66.73M(+8.5%) |
| Dec 2007 | -$61.89M(+26.2%) | -$17.96M(+0.4%) | -$61.51M(+7.7%) |
| Sep 2007 | - | -$17.89M(+42.0%) | -$57.09M(+10.8%) |
| Jun 2007 | - | -$12.60M(-3.4%) | -$51.52M(-0.1%) |
| Mar 2007 | - | -$13.05M(-3.7%) | -$51.59M(+6.5%) |
| Dec 2006 | -$49.05M(+41.0%) | -$13.55M(+10.0%) | -$48.45M(+6.7%) |
| Sep 2006 | - | -$12.32M(-2.8%) | -$45.39M(-0.6%) |
| Jun 2006 | - | -$12.67M(+27.8%) | -$45.67M(+16.5%) |
| Mar 2006 | - | -$9.91M(-5.5%) | -$39.20M(+12.7%) |
| Dec 2005 | -$34.78M(+40.3%) | -$10.49M(-16.7%) | -$34.78M(+10.8%) |
| Sep 2005 | - | -$12.59M(+103.1%) | -$31.39M(+26.5%) |
| Jun 2005 | - | -$6.20M(+12.9%) | -$24.81M(+2.6%) |
| Mar 2005 | - | -$5.49M(-22.6%) | -$24.19M(-2.4%) |
| Dec 2004 | -$24.79M(+100.0%) | -$7.10M(+18.0%) | -$24.79M(-32.9%) |
| Sep 2004 | - | -$6.02M(+7.9%) | -$36.97M(+27.0%) |
| Jun 2004 | - | -$5.58M(-8.5%) | -$29.10M(+13.8%) |
| Mar 2004 | - | -$6.10M(-68.4%) | -$25.57M(+17.5%) |
| Dec 2003 | -$12.40M(+10.5%) | -$19.27M(-1144.9%) | -$21.75M(+777.5%) |
| Sep 2003 | - | $1.84M(-190.3%) | -$2.48M(-42.7%) |
| Jun 2003 | - | -$2.04M(-10.5%) | -$4.32M(+89.5%) |
| Mar 2003 | - | -$2.28M | -$2.28M |
| Dec 2002 | -$11.22M(-26.5%) | - | - |
| Dec 2001 | -$15.28M(+35.6%) | - | - |
| Dec 2000 | -$11.27M | - | - |
FAQ
- What is ACADIA Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals annual EBITDA year-on-year change?
- What is ACADIA Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals quarterly EBITDA year-on-year change?
- What is ACADIA Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals TTM EBITDA year-on-year change?
What is ACADIA Pharmaceuticals annual EBITDA?
The current annual EBITDA of ACAD is $100.16M
What is the all time high annual EBITDA for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high annual EBITDA is $100.16M
What is ACADIA Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, ACAD annual EBITDA has changed by +$167.99M (+247.67%)
What is ACADIA Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of ACAD is $22.24M
What is the all time high quarterly EBITDA for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high quarterly EBITDA is $36.58M
What is ACADIA Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, ACAD quarterly EBITDA has changed by +$1.50M (+7.25%)
What is ACADIA Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of ACAD is $101.67M
What is the all time high TTM EBITDA for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high TTM EBITDA is $124.54M
What is ACADIA Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, ACAD TTM EBITDA has changed by +$95.60M (+1575.15%)